Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2006-07-11
Original market date: See footnote 1
1996-12-31
Product name:
PHENERGAN EXPECTORANT WITH CODEINE LIQUID
DIN:
02162180 Electronic product monograph is not available
Company:
COLUMBIA LABORATORIES CANADA INC
36
1111 Flint Road
North York
Ontario
Canada
M3J 3C7
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Oral
Number of active ingredient(s):
3
Schedule(s):
Narcotic (CDSA I)
American Hospital Formulary Service (AHFS): See footnote 3
48:08.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS
Active ingredient group (AIG) number:See footnote5
0311735001
Active ingredient(s) | Strength |
---|---|
CODEINE PHOSPHATE | 10 MG / 5 ML |
POTASSIUM GUAIACOL SULPHONATE | 40 MG / 5 ML |
PROMETHAZINE HYDROCHLORIDE | 5.65 MG / 5 ML |